Date Filed | Type | Description |
08/22/2023 |
SC 13D/A
| MANCHESTER MANAGEMENT CO LLC reports a 11.7% stake in Sanuwave Health, Inc. |
08/01/2023 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
07/27/2023 |
SC 13D/A
| MANCHESTER MANAGEMENT CO LLC reports a 13.1% stake in Sanuwave Health, Inc. |
06/30/2023 |
SC 13D/A
| MANCHESTER MANAGEMENT CO LLC reports a 15.7% stake in Modular Medical, Inc. |
02/10/2023 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
02/10/2023 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
08/10/2022 |
SC 13D
| MANCHESTER MANAGEMENT CO LLC reports a 8% stake in Sanuwave Health, Inc. |
08/04/2022 |
SC 13D
| Form SC 13D - General statement of acquisition of beneficial ownership: |
03/08/2022 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
02/28/2022 |
SC 13D/A
| MANCHESTER MANAGEMENT CO LLC reports a 30% stake in Modular Medical, Inc. |
02/17/2022 |
SC 13D/A
| MANCHESTER MANAGEMENT CO LLC reports a 30% stake in Modular Medical, Inc. |
02/14/2022 |
SC 13D/A
| MANCHESTER MANAGEMENT CO LLC reports a 30.6% stake in Modular Medical, Inc. |
02/10/2022 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
02/10/2022 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
09/24/2021 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
08/10/2021 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
04/08/2021 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
02/16/2021 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
02/16/2021 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
01/21/2021 |
SC 13G
| MANCHESTER MANAGEMENT CO LLC reports a 14.1% stake in NeuroOne Medical Technologies Corporation |
10/13/2020 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
10/05/2020 |
SC 13D/A
| MANCHESTER MANAGEMENT CO LLC reports a 13.5% stake in Cipherloc Corporation |
08/28/2020 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
08/05/2020 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
07/13/2020 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
02/05/2020 |
SC 13G
| MANCHESTER MANAGEMENT CO LLC reports a 9.3% stake in KinerjaPay Corp. |
02/14/2019 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
11/20/2018 |
SC 13D/A
| MANCHESTER MANAGEMENT CO LLC reports a 33.9% stake in Modular Medical, Inc. |
02/14/2018 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
08/23/2017 |
SC 13G
| MANCHESTER MANAGEMENT CO LLC reports a 6.1% stake in Aytu BioScience, Inc. |
02/08/2017 |
SC 13G/A
| MANCHESTER MANAGEMENT CO LLC reports a 4.6% stake in VolitionRX Limited |
02/16/2016 |
SC 13G/A
| TRANSDEL PHARMACEUTICALS INC reports a 0% stake in Imprimis Pharmaceuticals, Inc. |
02/16/2016 |
SC 13G/A
| MANCHESTER MANAGEMENT CO LLC reports a 7.8% stake in VolitionRX Limited |
12/04/2012 |
SC 13G
| MANCHESTER MANAGEMENT CO LLC reports a 6.1% stake in CUI Global, Inc. |
|